SARAJEVO (Bosnia and Herzegovina), December 27 (SeeNews) â Luxembourg-based Haden as failed to sell its remaining 15.95% stake in Bosnian drug maker Bosnalijek [SAJ:BSNLR] at an extraordinary auction on the Sarajevo Stock Exchange (SASE) earlier this week, bourse data showed.